Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Amazon Among Bidders for Signify Health

Amazon Among Bidders for Signify Health

-Wall Street Journal https://www.wsj.com/articles/amazon-among-bidders-for-signify-health-11661123042

byCharles Gross

August 21, 2022

1 minute read

-Wall Street Journal

https://www.wsj.com/articles/amazon-among-bidders-for-signify-health-11661123042

Euroseas Q1: Earnings Beat, Dividend, Comeback Of Charter Rates & More

By Nabaparna Bhattacharya

May 16, 12:50 PM

Euroseas Ltd. (NASDAQ:ESEA) reported a first-quarter FY23 net revenue decline of 7.6% year-over-year to $41.94 million, beating the consensus of…

ESEA

Ultragenyx Announces Completion Of Enrollment In Phase 3 Orbit And Cosmic Studies Evaluating Setrusumab For The Treatment Of Osteogenesis Imperfecta

By Benzinga Newsdesk

April 30, 8:11 AM

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) today announced that all patients have been enrolled across the Phase 3 Orbit and Cosmic studies evaluating setrusumab (UX143) in pediatric and young adult patients with

RARE

Deutsche Bank Maintains Hold on Vornado Realty, Lowers Price Target to $25

By Benzinga Newsdesk

October 13, 10:08 AM

Deutsche Bank analyst Derek Johnston maintains Vornado Realty (NYSE:VNO) with a Hold and lowers the price target from $33 to $25.

VNO

News

Aethlon Medical Says Due To Lack Of Further Patient Enrollment, Co., UPMC Are In Process Of Terminating Hemopurifier Study At UPMC

By Michael Horton

September 29, 4:14 PM

-Reuters

AEMD

Amazon Among Bidders for Signify Health

Related Posts

Euroseas Q1: Earnings Beat, Dividend, Comeback Of Charter Rates & More

Ultragenyx Announces Completion Of Enrollment In Phase 3 Orbit And Cosmic Studies Evaluating Setrusumab For The Treatment Of Osteogenesis Imperfecta

Deutsche Bank Maintains Hold on Vornado Realty, Lowers Price Target to $25

Aethlon Medical Says Due To Lack Of Further Patient Enrollment, Co., UPMC Are In Process Of Terminating Hemopurifier Study At UPMC